US FDA issues EUA for remdesivir for COVID-19 treatment
The EUA allows for remdesivir to be distributed in the US and administered intravenously by healthcare providers, as appropriate,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
NPPA allows six paracetamol APIS manufacturers to export 2000 MT
Permissions have been granted to Farmson Pharmaceuticals, Meghmani LLP, Sri Krishna Pharmaceutical, Granules India, Bharat…
GBRC signs MoU with Neuberg Supratech for coronavirus vaccine
Neuberg Supratech will look for immune markers for the COVID-19 positive patients with the use of its in-house high throughput…
CDSCO extends WHO-GMP/CoPP validity by six months
The validities of WHO GMP/CoPP expiring between March to August 2020 will be extended by six months from the date of expiry of the…
Cadila Healthcare to sell stake in Windlas Healthcare to Windlas Biotech for Rs 99.44 cr
The sale is expected to be completed within 10 business days
Pharma supply chain disruptions following Covid-19 outbreak eases; sector outlook revised to stable…
The global demand is largely expected to be stable for the industry owing to the inelastic nature of prescription drugs though…
CSIR identifies top 25 drugs/drug candidates for repurposing
Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs
Favipiravir exports during COVID-19 outbreak reaffirm India’s position as Pharmacy to the World:…
Favipiravir is the fourth most evaluated repurposed drug after HCQ, lopinavir/ritonavir combination, and recombinant interferon…
Pharma workforce post COVID-19
Experts share some of the most immediate and important changes that will be reflected in the pharma workforce and its management…
SNBNCBS develops nanomedicine for better immune power to treat viral infections
It alters oxidative stress in the body to aid immune cells to perform their natural functions more efficiently
Pharma sector requests time-bound relief in DPCO list citing APIs price rise
The prices of APIs used in hand sanitisers have also jumped significantly
DuPont’s XIVIA Xylitol demonstrates positive effects on skin microbial growth
Xylitol is utilized due to its hydrating properties within skin care products, and the research is showing interesting abilities…
‘This crisis has not only brought into focus the urgency but also the sheer need of partnering’
Gilles Toulemonde, CEO at Inova Software decodes how the life sciences industry can accelerate partnering against COVID-19 in an…
Premas Biotech announces development of vaccine against COVID-19
The triple antigen vaccine being developed by Premas Biotech is being designed to try to overcome presently known and possible…
‘Exploiting a chink in the armour of bacteria could result in new drug therapies’
The researchers from the University of Leeds have pieced together how bacteria build their outer, defensive wall - in essence, the…
Wockhardt’s QIDP status for WCK 6777 reflects unmet need and untapped market opportunity:…
WCK 6777 targets multidrug resistance bacterial infections where unmet need is high, translating to an untapped market…
Sesderma communicates the effectiveness of Lactyferrin Forte Solution for COVID-19
Lactyferrin (LF) is known to exhibit medicinal properties and strengthen the immune system
AI can play a big role in vaccine development for COVID-19
Deepak Jha, Deputy General Manager- AIPF (Artificial Intelligence Platform), NEC Technologies India elaborates on the role AI can…
DCGI approves Glenmark’s clinical trials of Favipiravir Antiviral tablets for COVID-19…
The product is a generic version of Avigan of Fujifilm Toyama Chemical, Japan, a subsidiary of Fujifilm Corporation
Lupin’s Pithampur Unit-1 facility receives EIR from US FDA
The inspection for the facility was conducted by the US FDA between February 3, 2020 and February 11, 2020 and concluded with two…